Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing? - The Lancet Infectious Diseases
Diagnostic biomarkers for active tuberculosis: progress and challenges | EMBO Molecular Medicine
Neutrophil-specific biomarkers as proxy for... | Documents | Open Research Africa
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect
Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test | aidsmap
Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine
Therapeutic host-directed strategies to improve outcome in tuberculosis | Mucosal Immunology
Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019 | SpringerLink
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid | Thorax
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis | NEJM
TropicalMed | Free Full-Text | Missing Cases of Bacteriologically Confirmed TB/DR-TB from the National Treatment Registers in West and North Sumatra Provinces, Indonesia
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments | Science Advances
Tuberculosis: Past, present and future of the treatment and drug discovery research - ScienceDirect
Figure 3 - Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia - Volume 22, Number 3—March 2016 - Emerging Infectious Diseases journal - CDC
Microorganisms | Free Full-Text | Diabetes-Associated Susceptibility to Tuberculosis: Contribution of Hyperglycemia vs. Dyslipidemia
Frontiers | Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
Weakening Tuberculosis Bacteria's Defenses May Speed Treatment and Thwart Drug Resistance | Newsroom | Weill Cornell Medicine
Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial | BMC Infectious Diseases | Full Text
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study | PLOS Medicine
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study | BMC Infectious Diseases | Full Text
Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study - International Journal of Infectious Diseases
4.2 Adult and adolescent algorithms | MSF Medical Guidelines
Frontiers | Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
![PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b2748c6b14c22d792915b1e9fc3db2be946ae59/3-Figure2-1.png "PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar")